Regeneration
The New Frontier in Anti-Aging
1st Edition
Will be published approx. on 17. November 2026
Book
Hardback
176 pages
978-1-041-00487-5 (ISBN)
Description
In a world where the quest for longevity has long been dominated by creams, supplements, and surgical interventions, a revolutionary shift is underway. Regeneration: The New Frontier in Anti-Aging delves into the emerging science that no longer seeks to slow aging-but to reverse it. This book explores how breakthroughs in cellular rejuvenation, tissue engineering, gene editing, and regenerative medicine are redefining what it means to grow old.
Drawing from cutting-edge research across molecular biology, biotechnology, and clinical practice, this work offers a panoramic view of how scientists and innovators are unlocking the body's innate capacity to repair, renew, and regenerate. What sets this book apart is its holistic integration of frontier science with ethical, social, and economic dimensions-bridging the lab and the living experience of aging.
Key Features:
A comprehensive overview of regenerative biology and its implications for human longevity.
In-depth analysis of breakthrough technologies such as stem cell therapy, CRISPR-based rejuvenation, and senolytic interventions.
Case studies of leading laboratories, clinical trials, and biotech startups driving the field forward.
Discussion of ethical challenges, accessibility, and future directions of age-reversal science.
Insights from leading researchers, physicians, and futurists on what lies ahead.
Regeneration: The New Frontier in Anti-Aging is an essential read for medical professionals, researchers, bioethicists, and curious readers eager to understand how science is rewriting humanity's oldest story-aging itself.
Drawing from cutting-edge research across molecular biology, biotechnology, and clinical practice, this work offers a panoramic view of how scientists and innovators are unlocking the body's innate capacity to repair, renew, and regenerate. What sets this book apart is its holistic integration of frontier science with ethical, social, and economic dimensions-bridging the lab and the living experience of aging.
Key Features:
A comprehensive overview of regenerative biology and its implications for human longevity.
In-depth analysis of breakthrough technologies such as stem cell therapy, CRISPR-based rejuvenation, and senolytic interventions.
Case studies of leading laboratories, clinical trials, and biotech startups driving the field forward.
Discussion of ethical challenges, accessibility, and future directions of age-reversal science.
Insights from leading researchers, physicians, and futurists on what lies ahead.
Regeneration: The New Frontier in Anti-Aging is an essential read for medical professionals, researchers, bioethicists, and curious readers eager to understand how science is rewriting humanity's oldest story-aging itself.
More details
Language
English
Place of publication
London
United Kingdom
Publishing group
Taylor & Francis Ltd
Target group
College/higher education
Professional and scholarly
Postgraduate and Professional Reference
Illustrations
12 s/w Tabellen, 25 s/w Zeichnungen, 25 s/w Abbildungen
12 Tables, black and white; 25 Line drawings, black and white; 25 Illustrations, black and white
Dimensions
Height: 234 mm
Width: 156 mm
ISBN-13
978-1-041-00487-5 (9781041004875)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Persons
Dr. Sandeep Kumar Singh is working as Assistant Professor in the All India Institute of Medical Sciences (AIIMS), Nagpur, MH, India. He is a well-trained neuroscientist with a strong background in Biochemistry and Biomedicine. He earned his PhD Degree in Biotechnology from the most prestigious institution, the "Capital of Knowledge" Banaras Hindu University, Varanasi, UP, India. His research interests include Neuroscience, Molecular Biology, Neurodegenerative diseases, Aging, Nutraceuticals and Nanomedicines. He has more than 12 years of experience in neuroscience research. He has used animal models' system to investigate the therapeutic potential for Alzheimer's disease using synthetic as well as natural compounds in Drosophila as a model system. Dr. Singh has published more than 65 articles in journals of international repute such as, (Journal of Alzheimer's disease, Pharmacological Research, Current Neuropharmacology, Open Biology (Royal Society), Neurotherapeutics, Neurotoxicity Research, Oxidative Medicine and Cellular Longevity, BBRC, Neurochemical Research, Neuroscience Letter, and Current Drug Metabolism etc.). He has been also credited with 12 book chapters and Editors of 5 books. He is also the member of editorial boards of several international journals related to field of neuroscience. He served as Guest Editor and handled a special issue in various International Journal related to the field of Neuroscience. He is also the member of several scientific societies viz. Indian Academy of Neurosciences, Alzheimer's and Related Disorders Society of India, American Academy of Neurology, International Society of Neurochemistry, American, and Society of Neurochemistry. Bentham Science Publisher (USA) has also appointed Dr. Singh as Bentham Ambassador. He has attended several scientific national and international conferences/symposium/workshops in India and abroad and presented his research work. As a resource person, he has delivered lectures and seminars in various schools and colleges across the country.
Shailendra Kumar Mishra is a molecular biologist with over five years of research experience in anti-ageing biology, longevity science, and age-related neurodegenerative disorders, with a particular emphasis on Alzheimer's disease. His research focuses on the molecular and genetic mechanisms underlying biological aging and their convergence with neurodegeneration, with the aim of identifying therapeutic strategies that promote healthy aging and extended health span.
Mishra has made notable contributions to aging research through his work on the hallmarks of aging and anti-ageing drug discovery. His scholarly contributions emphasize drug discovery and intervention strategies targeting genomic instability, mitochondrial dysfunction, cellular senescence, and altered intercellular communication. He co-authored the book Anti-Aging Drug Discovery on the Basis of Hallmarks of Aging (Elsevier, 2022) and published the review article Therapeutic Antiaging Strategies (2022), which outlines key genetic, cellular, and pharmacological interventions targeting aging pathways. He is also the co-editor of the forthcoming volume Reverse Aging: Current Research and Future Directions (expected 2026).
In similar, his Alzheimer's disease research addresses neuroinflammation, immune response, biomarkers, cerebrovascular pathology, and nutraceutical-based interventions. His recent book chapters published by Academic Press, Elsevier (2024) focus on biomarkers for Alzheimer's diagnosis, cerebrovascular targets, nutraceuticals, and genome-editing approaches for neurodegenerative diseases. Mishra is the co-founder of the Indian Scientific Education and Technology (ISET) Foundation and actively promotes interdisciplinary research and scientific education in aging and brain health.
Shailendra Kumar Mishra is a molecular biologist with over five years of research experience in anti-ageing biology, longevity science, and age-related neurodegenerative disorders, with a particular emphasis on Alzheimer's disease. His research focuses on the molecular and genetic mechanisms underlying biological aging and their convergence with neurodegeneration, with the aim of identifying therapeutic strategies that promote healthy aging and extended health span.
Mishra has made notable contributions to aging research through his work on the hallmarks of aging and anti-ageing drug discovery. His scholarly contributions emphasize drug discovery and intervention strategies targeting genomic instability, mitochondrial dysfunction, cellular senescence, and altered intercellular communication. He co-authored the book Anti-Aging Drug Discovery on the Basis of Hallmarks of Aging (Elsevier, 2022) and published the review article Therapeutic Antiaging Strategies (2022), which outlines key genetic, cellular, and pharmacological interventions targeting aging pathways. He is also the co-editor of the forthcoming volume Reverse Aging: Current Research and Future Directions (expected 2026).
In similar, his Alzheimer's disease research addresses neuroinflammation, immune response, biomarkers, cerebrovascular pathology, and nutraceutical-based interventions. His recent book chapters published by Academic Press, Elsevier (2024) focus on biomarkers for Alzheimer's diagnosis, cerebrovascular targets, nutraceuticals, and genome-editing approaches for neurodegenerative diseases. Mishra is the co-founder of the Indian Scientific Education and Technology (ISET) Foundation and actively promotes interdisciplinary research and scientific education in aging and brain health.
Content
Regeneration: Introduction, Theories, Types and Future Prospective Regenerations in Humans and Regeneration- Related Genes Anti-Aging Strategies: Replacing, Rejuvenation, and Regeneration WNT Signalling PATHWAY: A NEW FRONTIER IN REGENERATION AND ANTI-AGING Pluripotent Stem cell is key driver of regeneration Epigenetics and metabolic involvement in regeneration Micrornas play a critical role in activation of regeneration Role of immune-modulation in regeneration Nanomaterials and bioactive molecules are modern approaches for regeneration Pro-regenerative machinery involves in regeneration approach based anti-aging strategy